Genetix Biotherapeutics
The Associate Director, Lot Disposition leads end-to-end lot disposition activities for cell and gene therapy products, ensuring timely and compliant product release. The role provides strategic QA leadership across manufacturing, QC, supply chain, MSAT, and regulatory teams and serves as the business lead for a program to digitalize and automate the lot disposition process to support scalability.
Headquarters
Somerville, Massachusetts, United States
Company Size
1-10 employees
Founded
1993
Genetix Biotherapeutics, formerly bluebird bio, is a biotechnology company focused on developing and commercializing transformative one-time genetic therapies for patients with rare diseases, including sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy. The company markets three FDA-approved therapies—LYFGENIA, ZYNTEGLO, and SKYSONA—which are designed to treat the underlying genetic cause of disease using the patient's own blood stem cells. As a privately held company, Genetix Biotherapeutics is focused on commercial execution, scaling patient access, and improving the treatment experience for patients and providers.
Lonza and Genetix Biotherapeutics Extend Commercial Manufacturing Agreement for ZYNTEGLO
4 days ago
bluebird bio Rebrands as Genetix Biotherapeutics, Returning to Its Foundational Roots
Sep 18, 2025
After buyout, bluebird bio hatches familiar new branding as Genetix Biotherapeutics
Sep 18, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genetix Biotherapeutics.
Genetix Biotherapeutics didn’t post a salary, so this is our estimate from similar listings.
Genetix Announces 2025 Commercial Performance Results and Outlines 2026 Strategic Priorities
1 week ago
Senior Specialist, Quality Assurance Lot Disposition
Bristol Myers Squibb
Senior Specialist, QA Disposition
Bristol Myers Squibb
Specialist, QA Disposition
Bristol Myers Squibb
Director QA, GMP External Operations Cell and Genetic Therapies - VCGT
lifelancer
Manager, QA Batch Disposition
Catalent
Quality Assurance Specialist I, Raw Material Release. Sunday to Wednesday [Contract to Hire]
Iovance Biotherapeutics